AICAR, formerly known as AICA riboside, is a purine precursor with antineoplastic activity. It is important in treatment of metabolic diseases such as type 2 diabetes as well as possible treatment of various cancer types. References: Chung EJ, Efstathiou NE, Konstantinou EK, Maidana DE, Miller JW, Young LH, Vavvas DG. AICAR suppresses TNF-α-induced complement factor B in RPE cells. Sci Rep. 2017 Dec 15;7(1):17651. doi: 10.1038/s41598-017-17744-w. PubMed PMID: 29247196; PubMed Central PMCID: PMC5732305.

纯度：≥98%

CAS：3031-94-5